← Eichor
Location: San Francisco Synced from ClinicalTrials.gov · July 28, 2026

Clinical studies recruiting near San Francisco

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Comparison of Methods for Recording Post Operative Pain
NA · Zuckerberg San Francisco General Hospital · University of California, San Francisco · NCT06206148
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Speci
Phase 3 · University of California San Francisco · Corvus Pharmaceuticals, Inc. · NCT06561048
Androgens and NAFLD Longitudinal Cohort Study
Phase N/A · University of California San Francisco · University of California, San Francisco · NCT06124261
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Phase 2 · University of San Francisco · Johns Hopkins University · NCT07059091
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Phase N/A · University of California, San Francisco (UCSF) · Jasper Gerritsen · NCT06118723
Pilot Study of Pancreatic Cancer Screening
Phase N/A · University of California San Francisco · University of California, San Francisco · NCT05058846
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta
Phase 2 · Kaiser Permanente-San Francisco · National Cancer Institute (NCI) · NCT06029270
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard
Phase N/A · University of California San Francisco (UCSF) · Regeneron Pharmaceuticals · NCT06693531
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Phase N/A · University of San Francisco · Ascidian Therapeutics, Inc · NCT06445322
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Phase 3 · UC San Francisco Medical Center · Novartis Pharmaceuticals · NCT06597019
Treating Major Depression With Yoga Mono-therapy
NA · Zuckerberg San Francisco General Hospital · University of California, San Francisco · NCT06091527
The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women
Phase N/A · University of California, San Francisco · University of California, San Francisco · NCT07284082
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Kaiser Permanente-San Francisco · National Cancer Institute (NCI) · NCT05987241
Impact of Barostimulation on Hemodynamics in Adults With Heart Failure
NA · University of California San Francisco Health · Columbia University · NCT07335510
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · San Francisco Surg Ctr · Stryker Instruments · NCT03072927
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
Phase N/A · University of California - San Francisco · University of Michigan · NCT06104969
VIBRANT: VIB4920 for Active Lupus Nephritis
Phase 2 · University of California San Francisco School of Medicine: L · National Institute of Allergy and Infectious Diseases (NIAID · NCT05201469
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Phase 1 · University of California, San Francisco (UCSF) · Inhibrx Biosciences, Inc · NCT03715933
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
Phase N/A · University of California, San Francisco · University of California, San Francisco · NCT06633224
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The
Phase 3 · Kaiser Permanente-San Francisco · National Cancer Institute (NCI) · NCT06096844
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
NA · University of California, San Francisco · Johns Hopkins University · NCT06080698
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With
Phase 3 · University of California San Francisco · Janssen Research & Development, LLC · NCT07258511
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
Phase 2/Phase 3 · University of California San Francisco Medical Center · Columbia University · NCT02314988
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Phase 4 · University of California San Francisco- Zuckerburg San Franc · Amgen · NCT06072482
Near Infrared Spectroscopy (NIRS) for Assessment of Depression
NA · San Francisco Veterans Affairs Medical Center · University of California, San Francisco · NCT04061148
Alzheimer's Tau Platform: Master Protocol
Phase 2 · University of California, San Francisco · Paul S. Aisen · NCT06957418
A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · University of California, San Francisco · Nurix Therapeutics, Inc. · NCT05107674
Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty
Phase 3 · University of California San Francisco · University of California, San Francisco · NCT05300685
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Phase 2 · University of California, San Francisco · Sabine Mueller, MD, PhD · NCT05465174
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
Phase N/A · San Francisco VA Medical Center, San Francisco, CA · VA Office of Research and Development · NCT05128006
Look up another city
Look up another condition

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.